BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16973968)

  • 1. Negative regulation of VEGF-induced vascular leakage by blockade of angiotensin II type 1 receptor.
    Sano H; Hosokawa K; Kidoya H; Takakura N
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2673-80. PubMed ID: 16973968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
    Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma.
    Arafat HA; Gong Q; Chipitsyna G; Rizvi A; Saa CT; Yeo CJ
    J Am Coll Surg; 2007 May; 204(5):996-1005; discussion 1005-6. PubMed ID: 17481528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACE inhibition lowers angiotensin II-induced chemokine expression by reduction of NF-kappaB activity and AT1 receptor expression.
    Schmeisser A; Soehnlein O; Illmer T; Lorenz HM; Eskafi S; Roerick O; Gabler C; Strasser R; Daniel WG; Garlichs CD
    Biochem Biophys Res Commun; 2004 Dec; 325(2):532-40. PubMed ID: 15530425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of angiogenic factors in angiotensin II infusion model in association with tubulointerstitial injuries.
    Kitayama H; Maeshima Y; Takazawa Y; Yamamoto Y; Wu Y; Ichinose K; Hirokoshi K; Sugiyama H; Yamasaki Y; Makino H
    Am J Hypertens; 2006 Jul; 19(7):718-27. PubMed ID: 16814127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
    Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin type 1 receptor blocker restores podocyte potential to promote glomerular endothelial cell growth.
    Liang XB; Ma LJ; Naito T; Wang Y; Madaio M; Zent R; Pozzi A; Fogo AB
    J Am Soc Nephrol; 2006 Jul; 17(7):1886-95. PubMed ID: 16790514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth.
    Fujita M; Hayashi I; Yamashina S; Fukamizu A; Itoman M; Majima M
    Carcinogenesis; 2005 Feb; 26(2):271-9. PubMed ID: 15637093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential roles of angiotensin II in vascular endothelial growth factor expression in sleep apnea syndrome.
    Takahashi S; Nakamura Y; Nishijima T; Sakurai S; Inoue H
    Respir Med; 2005 Sep; 99(9):1125-31. PubMed ID: 16085213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular permeability induced by VEGF family members in vivo: role of endogenous PAF and NO synthesis.
    Brkovic A; Sirois MG
    J Cell Biochem; 2007 Feb; 100(3):727-37. PubMed ID: 17115409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel mechanism and role of angiotensin II induced vascular endothelial injury in hypertensive diastolic heart failure.
    Yamamoto E; Kataoka K; Shintaku H; Yamashita T; Tokutomi Y; Dong YF; Matsuba S; Ichijo H; Ogawa H; Kim-Mitsuyama S
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2569-75. PubMed ID: 17932313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiopoietin-1 reduces vascular endothelial growth factor-induced brain endothelial permeability via upregulation of ZO-2.
    Lee SW; Kim WJ; Jun HO; Choi YK; Kim KW
    Int J Mol Med; 2009 Feb; 23(2):279-84. PubMed ID: 19148554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decursin inhibits VEGF-mediated inner blood-retinal barrier breakdown by suppression of VEGFR-2 activation.
    Kim JH; Kim JH; Lee YM; Ahn EM; Kim KW; Yu YS
    J Cereb Blood Flow Metab; 2009 Sep; 29(9):1559-67. PubMed ID: 19536074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposing effect of angiopoietin-1 on VEGF-mediated disruption of endothelial cell-cell interactions requires activation of PKC beta.
    Wang Y; Pampou S; Fujikawa K; Varticovski L
    J Cell Physiol; 2004 Jan; 198(1):53-61. PubMed ID: 14584044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta3-integrin regulates vascular endothelial growth factor-A-dependent permeability.
    Robinson SD; Reynolds LE; Wyder L; Hicklin DJ; Hodivala-Dilke KM
    Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2108-14. PubMed ID: 15345507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimeric VEGF-E(NZ7)/PlGF promotes angiogenesis via VEGFR-2 without significant enhancement of vascular permeability and inflammation.
    Zheng Y; Murakami M; Takahashi H; Yamauchi M; Kiba A; Yamaguchi S; Yabana N; Alitalo K; Shibuya M
    Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2019-26. PubMed ID: 16794222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin downregulates angiotensin type 1 receptor transcription implications in capillary formation from endothelial cells.
    Mitra S; Wang X; Khaidakov M; Ding Z; Ayyadevera S; Hearnsberger E; Goyal T; Mehta JL
    J Cardiovasc Pharmacol; 2012 Aug; 60(2):187-92. PubMed ID: 22561363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual effect of angiotensin-converting enzyme inhibition on angiogenesis in type 1 diabetic mice.
    Ebrahimian TG; Tamarat R; Clergue M; Duriez M; Levy BI; Silvestre JS
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):65-70. PubMed ID: 15528473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of the ligand-RAGE pathway via the angiotensin II type I receptor is essential in the pathogenesis of diabetic atherosclerosis.
    Ihara Y; Egashira K; Nakano K; Ohtani K; Kubo M; Koga J; Iwai M; Horiuchi M; Gang Z; Yamagishi S; Sunagawa K
    J Mol Cell Cardiol; 2007 Oct; 43(4):455-64. PubMed ID: 17761193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adeno-associated virus vectors simultaneously encoding VEGF and angiopoietin-1 enhances neovascularization in ischemic rabbit hind-limbs.
    Chen F; Tan Z; Dong CY; Chen X; Guo SF
    Acta Pharmacol Sin; 2007 Apr; 28(4):493-502. PubMed ID: 17376288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.